Divi Coins wants to make their cryptocurrency as convenient and accessible as possible. The Divi Project is a new crypto company that closed their initial coin sale in November. The new crypto is looking to replace exchanges like Paypal or Venmo.
Geoff McCabe is the Co-founder and CEO at The Divi Project Tim Sanders is the CMO at The Divi Project. The pair joined Cheddar to explain why they think their new cryptocurrency will lead the market. Sanders stresses that as a company, Divi is attentive and responsive to their consumers' needs.
McCabe believes that in the future all cryptocurrencies will be interchangeable and exchanged via digital wallets. So for Divi, the key is to be adopted and trusted by as many people as possible. In terms of future steps, The Divi Project is looking to build out their own blockchain and wallet.
Mark Kaufman, science reporter at Mashable, discusses President Trump's surprising pick to lead the White House Office of Science and Technology Policy, atmospheric scientist Kelvin Droegemeier.
These are the headlines you Need2Know for Thursday.
The electric automaker said most factories would hit a run rate of 10,000 of the mass-market vehicles a week by the end of the year, suggesting the company could be on the path to achieving profitability. The company did still report a wider loss than expected for the current quarter, but it said it burned through less cash than in the first quarter.
These are the headlines you Need2Know.
These are the headlines you Need2Know.
Narcan, the nasal spray that saved Demi Lovato from overdosing, is now available without a prescription in 49 states. Roger Crystal, MD, CEO of Opiant Pharmaceuticals and founder of the drug, was interviewed Thursday by Cheddar.
These are the headlines you Need2Know.
These are the headlines you Need2Know.
A recent survey by research firm Cohn & Wolfe found that 86 percent of Americans think companies should be socially and environmentally responsible. Burt's Bees is carbon-neutral certified and hasn't sent any waste to a landfill since 2010. Paula Alexander, Director of Sustainable Business at the company, tells Cheddar why it's important to work for a company that makes a difference.
Peter Loftus, Reporter at the Wall Street Journal, is skeptical of pharmaceutical companies touting lower drug prices. Merck may be cutting prices on medications, Loftus told Cheddar, but the ones affected represent a smaller percentage of the company's total sales.
